Cancer Biomedical Informatics Grid

Dies ist eine alte Version dieser Seite, zuletzt bearbeitet am 10. September 2013 um 01:01 Uhr durch W Nowicki (Diskussion | Beiträge) (trim some of the links per WP:EL). Sie kann sich erheblich von der aktuellen Version unterscheiden.

Vorlage:Lowercase title

The caBIG logo

The cancer Biomedical Informatics Grid (caBIG) was a US government program to develop an open source, open access information network called caGrid for secure data exchange on cancer research. The initiative was developed by the National Cancer Institute (part of the National Institutes of Health) and was maintained by the Center for Biomedical Informatics and Information Technology (CBIIT). In 2011 a report on caBIG raised significant questions about effectiveness and oversight, and its budget and scope were significantly trimmed. In 2012, the National Cancer Informatics Program (NCIP) was created as caBIG's successor program.

History

The National Cancer Institute (NCI) of the United States funded the cancer Biomedical Informatics Grid (caBIG) initiative in spring 2004, headed by Kenneth Buetow.[1] It goal was to connect US biomedical cancer researchers using technology known as grid computing. The program, led by the Center for Bioinformatics and Information Technology (CBIIT), began with a 3-year pilot phase. The pilot phase concluded in March 2007, and 56 NCI-designated cancer centers started a trial.[2]

In addition to caGrid, the underlying infrastructure for data sharing among organizations, caBIG developed software tools, data sharing policies, and common standards and vocabularies to facilitate data sharing.

Software tools targeted:

  • Collection, analysis, and management of basic research data
  • Clinical trials management, from patient enrollment to adverse event reporting and analysis
  • Collection, annotation, sharing, and storage of medical imaging data
  • Biospecimen management

Impact

caBIG sought to provide foundational technology for an approach to biomedicine it called a “learning healthcare system.”[3] This model of research and care delivery relies on the rapid exchange of information between all sectors of research and care, so that researchers and clinicians are able to collaboratively review and accurately incorporate the latest findings into their work. The ultimate goal is to speed the biomedical research process, leading to improved patient outcomes and more efficient healthcare delivery. This approach is often called Personalized Medicine where the right patient is given the right drug, at the right time. caBIG technology was used in adaptive clinical trials such as the I-SPY2 TRIAL[4] (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging and molecular AnaLysis 2), which are designed to use biomarkers to determine the appropriate therapy for women with advanced breast cancer. By collecting and analyzing clinical data in (nearly) real-time, patients' responses to therapy can be rapidly assessed to measure the effectiveness of a particular treatment, and clinical decisions may be refined to achieve optimal outcomes.

Health information technology

Health information technology (HIT) was promoted for management and secure exchange of medical information between researchers, health care providers, and consumers. HIT initiatives mentioning caBIG were:

  • Electronic Health Records – NCI and the American Society of Clinical Oncology (ASCO) have initiated a collaboration to create an oncology-specific EHR that utilizes caBIG standards for interoperability and that will enable oncologists to manage patient information in an electronic format that accurately captures the specific interventional issues unique to oncology.
  • Family Health History Tool[5] – CBIIT hosts the Family Health History Tool, a web-based application developed by the U.S. Department of Health and Human Services (HHS) to allow users to track and share family health information with healthcare providers to inform decisions about prevention, diagnosis and treatment.
  • Nationwide Health Information Network – An initiative to share patient clinical data across geographically disparate sources and create electronically-linked national health information exchange.

Collaborations

A BIG Health Consortium was formed in 2008 to promote personalized medicine, but disbanded in 2012.[6] In July 2009, caBIG announced a collaboration with the Dr. Susan Love Research Foundation to build an online cohort of women willing to participate in clinical trials.[7] Called the Army of Women, it had a goal of one million in its database; by December 2009 the site was "launched", and about 30,000 women and men signed up by 2010.[8]

The Cancer Genome Atlas (TCGA) was supported by caBIG. CGA aims to characterize more than 10,000 tumors across at least 20 cancers by 2015. caBIG provided connectivity, data standards, and tools to collect, organize, share, and analyze the diverse research data in its database. Since 2007, NCI worked with UK National Cancer Research Institute (NCRI). The two organizations shared technologies for collaborative research and the secure exchange of research data using caGrid and the NCRI Oncology Information Exchange (ONIX) portal. The Duke Cancer Institute used caBIG clinical trials tools in their collaboration with the Beijing Cancer Hospital of Peking University.[9]

Implementation

Participating institutions could either “adopt” caBIG tools to share data directly through caGrid, or “adapt” commercial or in-house developed software to be caBIG-compatible. The caBIG program developed software development kits (SDKs) for interoperable software tools, and detailed instructions on the process of adapting existing tools or developing new applications to be caBIG-compatible.

Programs

  • Cancer Centers Program[10] – Most of the 65 NCI-designated cancer centers use caBIG technology to report and retrieve data. caBIG was originally developed specifically to connect these centers as a way to enable collaborative research and eliminate data disconnects that slow down the development of personalized medicine.
  • NCI Community Cancer Centers Program[11] – The NCCCP is a program to test the concept of a national network of community-based cancer centers. Many of the 16 centers in the program are implementing caBIG tools in support of their research and care programs.
  • Enterprise Support Network (ESN)[12] – The ESN is a diverse collection of organizations that support the caBIG community by providing services, mentoring and expertise. The ESN program includes Knowledge Centers[13] that provide domain-specific expertise to assist users about caBIG tools and their applications, and Support Service Providers,[14] which are third party organizations that provide assistance to end-users and organizations adopting caBIG technology on a contract-for-services basis.

Open source

Since 2004, the caBIG program used open source communities, adapted from other public-private partnerships. The caBIG program produced new software for use in cancer research under contract to software development teams largely within the extramural research community. This has allowed the software to be produced by the teams who know best what the final products should do. Generally, these teams use in-house subject matter experts to define requirements, build functional software, and test the software as part of their own productions in their operations ensuring that it is a good fit across the potential user base. These teams also source the critical software engineering skills in exactly the same way that other government and commercial enterprises do – from the most readily available, best skilled, and most economical sources. The competitive proposal process ensures this engagement of resources and the best value to the American taxpayer for the project dollars expended. It is important to note that sometimes US based sources have not had the capacity or best economic value in these competitive bids. Vorlage:Citation needed

In general, software developed under US government contracts are the property of the US government and the US taxpayers. Depending on the terms in specific contracts, they might be accessible only by request under the Freedom of Information Act (FOIA). The timeliness of response to such requests might preclude a requester from ever gaining any secondary value from software released under a FOIA request.

The caBIG program placed the all caBIG software in a software repository freely accessible for download. Just like any other open source development community, anyone can modify the downloaded software; however, the licensing applied to the downloaded software allows far greater flexibility than is typical. An individual or enterprise is allowed to contribute the modified code back to the caBIG program but is not required to do so. Likewise, the modifications can be made available as open source but are not required to be made available as open source. The caBIG licensing even allows the use of the caBIG applications and components, combined with additions and modifications, to be released as commercial products. These aspects of the caBIG program actually encourage commercialization of caBIG technology in a way that is generally atypical of open-source initiatives.

In 2008, GlaxoSmithKline announced it would share cancer cell genomic data with caBIG.[15] Some private companies claimed benefits from caBIG technology in 2010.[16]

Criticism

By 2008, some questioned if the program was benefiting large pharmaceutical companies.[17] By 2011, the project had spent an estimated $350 million.[18] Although the goal was considered laudible, much of the software was unevenly adopted after being developed at great expense to compete with commercial offerings. In March 2011, an NCI working group assessment concluded that caBIG "...expanded far beyond those goals to implement an overly complex and ambitious software enterprise of NCI-branded tools, especially in the Clinical Trial Management System (CTMS) space. These have produced limited traction in the cancer community, compete against established commercial vendors, and create financially untenable long-term maintenance and support commitments for the NCL".[2] In 2012, the NCI announced a new program the National Cancer Informatics Program (NCIP) as a successor to caBIG.[19][20]

References

Vorlage:Reflist

Further reading

  1. Kenneth Buetow: Heading for the BIG Time In: The Scientist, April 1, 2008, S. 60 
  2. a b Board of Scientific Advisors Ad Hoc Working Group: An Assessment of the Impact of the NCI Cancer Biomedical Informatics Grid (caBIG®). National Cancer Institute, 3. März 2011, abgerufen am 4. Oktober 2011.
  3. A Learning Healthcare System for Cancer Care.
  4. Barker AD, Sigman CC, Kelloff GJ, Hylton NM, Berry DA, Esserman LJ: I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. In: Clinical Pharmacology and Therapeutics. 86. Jahrgang, Nr. 1, Juli 2009, S. 97–100, doi:10.1038/clpt.2009.68, PMID 19440188.
  5. Family Health History Tool.
  6. BIG Health Consortium. Archiviert vom Original am 13. Februar 2009; abgerufen am 10. Juni 2013.
  7. Edyta Zielinska: NCI tackles trial enrollment In: The Scientist, July 22, 2009. Abgerufen im October 4, 2011 
  8. Health of Women study. In: Army of Women website. Archiviert vom Original am 30. Mai 2010; abgerufen am 4. Oktober 2011.
  9. Duke plays a major role in a nationwide project for improving cancer care In: Cancer Center Notes, Duke Comprehensive Cancer Center, March 2004, S. 6 
  10. Cancer Centers Program.
  11. NCI Community Cancer Centers Program.
  12. Enterprise Support Network.
  13. caBIG Knowledge Centers.
  14. caBIG Support Service Providers.
  15. GlaxoSmithKline collaborates with National Cancer Institute to make large body of cancer cell genomic data available to all cancer researchers (Memento des Originals vom June 27, 2008 im Internet Archive) In: Press release, cancer cell genomic data available. Abgerufen im June 10, 2013 
  16. An Unexpected and Fortuitous Synergy: BIGR® and caBIG®. In: Company website. HealthCare IT, Inc., archiviert vom Original; abgerufen am 10. Juni 2013.
  17. Gareth Halfacree: Cancer research goes open. 23. Juni 2008, abgerufen am 10. Juni 2013.
  18. John Foley: Report Blasts Problem-Plagued Cancer Research Grid In: Information Week, April 8, 2011. Abgerufen im June 10, 2013 
  19. Uduak Grace Thomas: NCI Reorganizes Cancer Informatics Efforts; Cuts Some caBIG Programs, Moves Others to NCIP In: BIOINFORM, April 20, 2012. Abgerufen im April 25, 2012 
  20. George A. Komatsoulis: Program Announcement. National Cancer Institute, archiviert vom Original am 30. Juli 2012; abgerufen am 10. Juni 2013.